secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001493152-24-022977
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

TenX Keane pays additional $268,645 to redeeming shareholders after redemption price miscalculation
--------------------------------------------------------------------------------

- Holders of 2,287,923 shares redeemed at $10.90/share on Jan 17, 2024, for ~$24.9M.
- Correct redemption price should have been $11.02/share, based on Jan 12, 2024 calculation.
- On May 31, 2024, company paid $268,645 aggregate top-up to cover the $0.12/share shortfall.
- Total redemption amount adjusted to ~$25.2M using corrected price of $11.02 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224022977/0001493152-24-022977-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000149315224022977/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-022977

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer